Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria

The most commonly used antibiotics in Crohn's disease are nitroimidazoles and macrolides often combined with corticosteroids or sulfasalazine. There has been interest in a mycobacterial involvement in Crohn's disease since its earliest description. It is not recognized that Mycobacterium a...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2000-03, Vol.45 (3), p.445-456
Main Authors: HULTEN, K, ALMASHHRAWI, A, EL-ZAATARI, F. A. K, GRAHAM, D. Y
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Clinical Trials as Topic
Crohn Disease - drug therapy
Crohn Disease - microbiology
Humans
Medical sciences
Paratuberculosis - drug therapy
Pharmacology. Drug treatments
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c334t-2294a5f9e9e63b084de0183c619b891e7e23c73452d9e4a2ad2f4befc1479b113
cites
container_end_page 456
container_issue 3
container_start_page 445
container_title Digestive diseases and sciences
container_volume 45
creator HULTEN, K
ALMASHHRAWI, A
EL-ZAATARI, F. A. K
GRAHAM, D. Y
description The most commonly used antibiotics in Crohn's disease are nitroimidazoles and macrolides often combined with corticosteroids or sulfasalazine. There has been interest in a mycobacterial involvement in Crohn's disease since its earliest description. It is not recognized that Mycobacterium avium subspecies paratuberculosis, a proven but uncommon cause of human disease, is widespread in the human food chain especially in dairy products and beef. M. paratuberculosis has been identified in tissues from a higher proportion of Crohn's disease patients than controls, suggesting that it may be one of the causes of Crohn's disease. We review the large number of antibiotic trials in Crohn's disease. Although studies have been performed with many different protocols and variations in the definition of success, preliminary reports of multiple drug therapies are encouraging. Nevertheless, large-well designed preferably placebo-controlled studies are needed before one could recommend such therapy.
doi_str_mv 10.1023/A:1005453409445
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71004088</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71004088</sourcerecordid><originalsourceid>FETCH-LOGICAL-c334t-2294a5f9e9e63b084de0183c619b891e7e23c73452d9e4a2ad2f4befc1479b113</originalsourceid><addsrcrecordid>eNpdkEtLAzEQgIMotlbP3iSI6Gk1k2Qf6a0UX1Dwouclm51tU_ZlslXqrzdgq-Bp5vDNx_ARcg7sFhgXd7MpMBbLWEimpIwPyBjiVEQ8TrJDMmaQhB0gGZET79eMMZVCckxGwFKpBCRjUs3awRbaDOisrumwQqf7La06R-euW7U3npbWo_ZIp3RGHX5Y_KTY9Cvt7Zdtl78npXUYNCXVS21bP9Bma7q9-ZQcVbr2eLabE_L2cP86f4oWL4_P89kiMkLIIeJcSR1XChUmomCZLJFBJkwCqsgUYIpcmFTImJcKpea65JUssDIgU1UAiAm5_vH2rnvfoB_yxnqDda1b7DY-T0MuybIsgJf_wHW3cW34LecghQh1VYAudtCmaLDMe2cb7bb5Pl8ArnaA9kbXldOtsf6PCxohYvENe6N9-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214331029</pqid></control><display><type>article</type><title>Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria</title><source>Springer Link</source><creator>HULTEN, K ; ALMASHHRAWI, A ; EL-ZAATARI, F. A. K ; GRAHAM, D. Y</creator><creatorcontrib>HULTEN, K ; ALMASHHRAWI, A ; EL-ZAATARI, F. A. K ; GRAHAM, D. Y</creatorcontrib><description>The most commonly used antibiotics in Crohn's disease are nitroimidazoles and macrolides often combined with corticosteroids or sulfasalazine. There has been interest in a mycobacterial involvement in Crohn's disease since its earliest description. It is not recognized that Mycobacterium avium subspecies paratuberculosis, a proven but uncommon cause of human disease, is widespread in the human food chain especially in dairy products and beef. M. paratuberculosis has been identified in tissues from a higher proportion of Crohn's disease patients than controls, suggesting that it may be one of the causes of Crohn's disease. We review the large number of antibiotic trials in Crohn's disease. Although studies have been performed with many different protocols and variations in the definition of success, preliminary reports of multiple drug therapies are encouraging. Nevertheless, large-well designed preferably placebo-controlled studies are needed before one could recommend such therapy.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1023/A:1005453409445</identifier><identifier>PMID: 10749316</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Clinical Trials as Topic ; Crohn Disease - drug therapy ; Crohn Disease - microbiology ; Humans ; Medical sciences ; Paratuberculosis - drug therapy ; Pharmacology. Drug treatments</subject><ispartof>Digestive diseases and sciences, 2000-03, Vol.45 (3), p.445-456</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Mar 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c334t-2294a5f9e9e63b084de0183c619b891e7e23c73452d9e4a2ad2f4befc1479b113</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1310335$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10749316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HULTEN, K</creatorcontrib><creatorcontrib>ALMASHHRAWI, A</creatorcontrib><creatorcontrib>EL-ZAATARI, F. A. K</creatorcontrib><creatorcontrib>GRAHAM, D. Y</creatorcontrib><title>Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>The most commonly used antibiotics in Crohn's disease are nitroimidazoles and macrolides often combined with corticosteroids or sulfasalazine. There has been interest in a mycobacterial involvement in Crohn's disease since its earliest description. It is not recognized that Mycobacterium avium subspecies paratuberculosis, a proven but uncommon cause of human disease, is widespread in the human food chain especially in dairy products and beef. M. paratuberculosis has been identified in tissues from a higher proportion of Crohn's disease patients than controls, suggesting that it may be one of the causes of Crohn's disease. We review the large number of antibiotic trials in Crohn's disease. Although studies have been performed with many different protocols and variations in the definition of success, preliminary reports of multiple drug therapies are encouraging. Nevertheless, large-well designed preferably placebo-controlled studies are needed before one could recommend such therapy.</description><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Clinical Trials as Topic</subject><subject>Crohn Disease - drug therapy</subject><subject>Crohn Disease - microbiology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Paratuberculosis - drug therapy</subject><subject>Pharmacology. Drug treatments</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNpdkEtLAzEQgIMotlbP3iSI6Gk1k2Qf6a0UX1Dwouclm51tU_ZlslXqrzdgq-Bp5vDNx_ARcg7sFhgXd7MpMBbLWEimpIwPyBjiVEQ8TrJDMmaQhB0gGZET79eMMZVCckxGwFKpBCRjUs3awRbaDOisrumwQqf7La06R-euW7U3npbWo_ZIp3RGHX5Y_KTY9Cvt7Zdtl78npXUYNCXVS21bP9Bma7q9-ZQcVbr2eLabE_L2cP86f4oWL4_P89kiMkLIIeJcSR1XChUmomCZLJFBJkwCqsgUYIpcmFTImJcKpea65JUssDIgU1UAiAm5_vH2rnvfoB_yxnqDda1b7DY-T0MuybIsgJf_wHW3cW34LecghQh1VYAudtCmaLDMe2cb7bb5Pl8ArnaA9kbXldOtsf6PCxohYvENe6N9-w</recordid><startdate>20000301</startdate><enddate>20000301</enddate><creator>HULTEN, K</creator><creator>ALMASHHRAWI, A</creator><creator>EL-ZAATARI, F. A. K</creator><creator>GRAHAM, D. Y</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20000301</creationdate><title>Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria</title><author>HULTEN, K ; ALMASHHRAWI, A ; EL-ZAATARI, F. A. K ; GRAHAM, D. Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c334t-2294a5f9e9e63b084de0183c619b891e7e23c73452d9e4a2ad2f4befc1479b113</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Clinical Trials as Topic</topic><topic>Crohn Disease - drug therapy</topic><topic>Crohn Disease - microbiology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Paratuberculosis - drug therapy</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HULTEN, K</creatorcontrib><creatorcontrib>ALMASHHRAWI, A</creatorcontrib><creatorcontrib>EL-ZAATARI, F. A. K</creatorcontrib><creatorcontrib>GRAHAM, D. Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HULTEN, K</au><au>ALMASHHRAWI, A</au><au>EL-ZAATARI, F. A. K</au><au>GRAHAM, D. Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>2000-03-01</date><risdate>2000</risdate><volume>45</volume><issue>3</issue><spage>445</spage><epage>456</epage><pages>445-456</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><notes>ObjectType-Article-2</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-3</notes><notes>content type line 23</notes><notes>ObjectType-Review-1</notes><abstract>The most commonly used antibiotics in Crohn's disease are nitroimidazoles and macrolides often combined with corticosteroids or sulfasalazine. There has been interest in a mycobacterial involvement in Crohn's disease since its earliest description. It is not recognized that Mycobacterium avium subspecies paratuberculosis, a proven but uncommon cause of human disease, is widespread in the human food chain especially in dairy products and beef. M. paratuberculosis has been identified in tissues from a higher proportion of Crohn's disease patients than controls, suggesting that it may be one of the causes of Crohn's disease. We review the large number of antibiotic trials in Crohn's disease. Although studies have been performed with many different protocols and variations in the definition of success, preliminary reports of multiple drug therapies are encouraging. Nevertheless, large-well designed preferably placebo-controlled studies are needed before one could recommend such therapy.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>10749316</pmid><doi>10.1023/A:1005453409445</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0163-2116
ispartof Digestive diseases and sciences, 2000-03, Vol.45 (3), p.445-456
issn 0163-2116
1573-2568
language eng
recordid cdi_proquest_miscellaneous_71004088
source Springer Link
subjects Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Biological and medical sciences
Clinical Trials as Topic
Crohn Disease - drug therapy
Crohn Disease - microbiology
Humans
Medical sciences
Paratuberculosis - drug therapy
Pharmacology. Drug treatments
title Antibacterial therapy for Crohn's disease : A review emphasizing therapy directed against mycobacteria
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-23T02%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibacterial%20therapy%20for%20Crohn's%20disease%20:%20A%20review%20emphasizing%20therapy%20directed%20against%20mycobacteria&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=HULTEN,%20K&rft.date=2000-03-01&rft.volume=45&rft.issue=3&rft.spage=445&rft.epage=456&rft.pages=445-456&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1023/A:1005453409445&rft_dat=%3Cproquest_pubme%3E71004088%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c334t-2294a5f9e9e63b084de0183c619b891e7e23c73452d9e4a2ad2f4befc1479b113%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=214331029&rft_id=info:pmid/10749316&rfr_iscdi=true